Aug 4, 2026 05:22PM
Aug 4, 2026 05:20PM
Jul 27, 2026 05:14PM
Jul 27, 2026 05:12PM
Jun 12, 2026 05:41PM
Jun 12, 2026 05:39PM
Jun 8, 2026 03:02AM BioGene Therapeutics appoints Ty Howton to board of directors
Jun 8, 2026 03:00AM
May 19, 2026 07:37PM
May 19, 2026 07:36PM
May 12, 2026 05:03PM
May 12, 2026 05:02PM
Apr 22, 2026 03:03AM
Apr 22, 2026 03:00AM PreveCeutical Announces Non-Brokered Private Placement
Mar 30, 2026 03:02AM
Mar 30, 2026 03:00AM
Mar 12, 2026 03:02AM
Mar 12, 2026 03:00AM
Feb 25, 2026 03:00AM
Feb 9, 2026 03:00AM
Nov 26, 2025 07:00AM PreveCeutical Medical and BioGene Therapeutics Announce Closing of Plan of Arrangement
Nov 20, 2025 12:26PM
Nov 20, 2025 07:00AM
Oct 30, 2025 07:03AM
Oct 30, 2025 07:00AM
Oct 20, 2025 07:00AM
Oct 10, 2025 04:02PM
Oct 10, 2025 04:00PM PreveCeutical Announces Results from Annual General and Special Meeting and Increase to Size of Non-Brokered Private Placement
Sep 19, 2025 06:00PM
Sep 5, 2025 05:00PM
Sep 5, 2025 04:58PM
Sep 4, 2025 04:00PM
Aug 28, 2025 06:00PM
Aug 20, 2025 07:02AM
Aug 20, 2025 07:00AM BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer
Aug 19, 2025 07:00AM
Jul 9, 2025 07:00AM
Jun 30, 2025 11:53AM
Jun 25, 2025 07:00AM
Jun 11, 2025 05:19PM
Jun 2, 2025 07:00AM
May 26, 2025 07:00AM PreveCeutical Welcomes Stephen Glover as Corporate Advisor
May 22, 2025 02:25PM
May 14, 2025 07:00AM
Apr 28, 2025 04:00PM
Apr 14, 2025 09:45PM
Apr 2, 2025 07:04PM
Mar 10, 2025 06:00PM
Feb 6, 2025 07:00AM PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease
Feb 4, 2025 07:00AM

442,441 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All